Mark Hiatt

Mark Hiatt currently serves in multiple high-level roles, including Senior Vice President of Market Access + Strategy at BostonGene, Chief Medical Officer and Vice President of Clinical Applications at FrontRunnerHC, and Chief Medical Officer at RadSite, among others. With a robust background in healthcare leadership, Hiatt has specialized in promoting AI technologies in cancer treatment and enhancing patient experience. Previous positions include Vice President of Medical Affairs at Guardant Health and Executive Medical Director at Regence BlueCross BlueShield of Utah, with a focus on clinical management and physician engagement. Hiatt's academic credentials include medical degrees and advanced studies from renowned institutions such as Wake Forest University and Stanford University, with a particular emphasis on healthcare management and informatics.